Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)
Bull Cancer. 2023 Dec 11:S0007-4551(23)00441-1. doi: 10.1016/j.bulcan.2023.10.010. Online ahead of print.ABSTRACTThe treatment of chronic myeloid leukemia relies on orally available tyrosine kinase inhibitors targeting the BCR::ABL1 oncoprotein. Bosutinib is a second generation adenosine triphosphate-competitive inhibitor approved for use in frontline adult chronic phase-chronic myeloid leukemia and all phases-chronic myeloid leukemia in the second line setting or beyond. Its efficacy was demonstrated in several pivotal clinical trials at 400mg once daily in the first line context and at 500mg once daily beyond first line....
Source: Bulletin du Cancer - December 13, 2023 Category: Cancer & Oncology Authors: Delphine Rea Emilie Cayssials Aude Charbonnier Val érie Coiteux Gabriel Etienne Lauriane Goldwirt Agn ès Guerci-Bresler Fran çoise Huguet Laurence Legros Lydia Roy Franck Emmanuel Nicolini Source Type: research
Place of innovative therapies in the management of cervical cancer
Bull Cancer. 2023 Dec 11:S0007-4551(23)00429-0. doi: 10.1016/j.bulcan.2023.10.007. Online ahead of print.ABSTRACTDespite optimized screening and prevention strategies, cervical cancer remains a major public health problem, even in developed countries. In France, the incidence is estimated at 3159 cases per year in 2023. While the management of early-stage cases is now highly standardized, few therapeutic advances were made in the treatment of metastatic stages before 2021, before the therapeutic arsenal that we know today took off. The aim of this review is to summarize these advances.PMID:38087730 | DOI:10.1016/j.bulcan.2...
Source: Bulletin du Cancer - December 13, 2023 Category: Cancer & Oncology Authors: Diana Bello Roufai Source Type: research
Patients treated with anticancer drugs: Practices and expectations of community pharmacists
The objective of this work is to study this pharmacotherapeutic management, for all routes of administration considered.METHODS: This observational study is based on a questionnaire and semi-structured interviews conducted with community pharmacists in contact with the Unité médicale ambulatoire de cancérologie (UMAC) of the University Hospital of Dijon.RESULTS: The main objective of community pharmacists is to ensure that patients understand and comply with their treatment. Twenty-one percent of them have already implemented oral anticancer drug interviews. Sixty-five percent have partial information about the injectab...
Source: Bulletin du Cancer - December 13, 2023 Category: Cancer & Oncology Authors: Florent Mac é Mathieu Boulin Am élie Cransac Pauline Pistre Christine Peyron Source Type: research
Sodium thiosulfate in preventing ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors
Bull Cancer. 2023 Dec 12:S0007-4551(23)00438-1. doi: 10.1016/j.bulcan.2023.11.003. Online ahead of print.NO ABSTRACTPMID:38092636 | DOI:10.1016/j.bulcan.2023.11.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 13, 2023 Category: Cancer & Oncology Authors: Arnaud Saillant Luca Campedel Source Type: research
Pembrolizumab with trastuzumab and chemotherapy-advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS ≥1
Bull Cancer. 2023 Dec 8:S0007-4551(23)00439-3. doi: 10.1016/j.bulcan.2023.11.004. Online ahead of print.NO ABSTRACTPMID:38071114 | DOI:10.1016/j.bulcan.2023.11.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: In ès Lévêque El éonore Spitzer Source Type: research
Impact of the withdrawal of macrotextured implant on reconstruction practices
CONCLUSION: Since the recall of macrotextured breast implants, the reconstruction rate has decreased in our centre in favor of autologous techniques with lower complication rates.PMID:38071115 | DOI:10.1016/j.bulcan.2023.10.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: Maxime Martinez Cl émentine Jankowski Laura Vincent Pierre Burnier Charles Coutant Source Type: research
Pembrolizumab with trastuzumab and chemotherapy-advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS ≥1
Bull Cancer. 2023 Dec 8:S0007-4551(23)00439-3. doi: 10.1016/j.bulcan.2023.11.004. Online ahead of print.NO ABSTRACTPMID:38071114 | DOI:10.1016/j.bulcan.2023.11.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: In ès Lévêque El éonore Spitzer Source Type: research
Impact of the withdrawal of macrotextured implant on reconstruction practices
CONCLUSION: Since the recall of macrotextured breast implants, the reconstruction rate has decreased in our centre in favor of autologous techniques with lower complication rates.PMID:38071115 | DOI:10.1016/j.bulcan.2023.10.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: Maxime Martinez Cl émentine Jankowski Laura Vincent Pierre Burnier Charles Coutant Source Type: research
Pembrolizumab with trastuzumab and chemotherapy-advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS ≥1
Bull Cancer. 2023 Dec 8:S0007-4551(23)00439-3. doi: 10.1016/j.bulcan.2023.11.004. Online ahead of print.NO ABSTRACTPMID:38071114 | DOI:10.1016/j.bulcan.2023.11.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: In ès Lévêque El éonore Spitzer Source Type: research
Impact of the withdrawal of macrotextured implant on reconstruction practices
CONCLUSION: Since the recall of macrotextured breast implants, the reconstruction rate has decreased in our centre in favor of autologous techniques with lower complication rates.PMID:38071115 | DOI:10.1016/j.bulcan.2023.10.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: Maxime Martinez Cl émentine Jankowski Laura Vincent Pierre Burnier Charles Coutant Source Type: research
Pembrolizumab with trastuzumab and chemotherapy-advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS ≥1
Bull Cancer. 2023 Dec 8:S0007-4551(23)00439-3. doi: 10.1016/j.bulcan.2023.11.004. Online ahead of print.NO ABSTRACTPMID:38071114 | DOI:10.1016/j.bulcan.2023.11.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: In ès Lévêque El éonore Spitzer Source Type: research
Impact of the withdrawal of macrotextured implant on reconstruction practices
CONCLUSION: Since the recall of macrotextured breast implants, the reconstruction rate has decreased in our centre in favor of autologous techniques with lower complication rates.PMID:38071115 | DOI:10.1016/j.bulcan.2023.10.009 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 9, 2023 Category: Cancer & Oncology Authors: Maxime Martinez Cl émentine Jankowski Laura Vincent Pierre Burnier Charles Coutant Source Type: research
Permanent suicide
Bull Cancer. 2023 Dec 7:S0007-4551(23)00435-6. doi: 10.1016/j.bulcan.2023.11.001. Online ahead of print.NO ABSTRACTPMID:38065701 | DOI:10.1016/j.bulcan.2023.11.001 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 8, 2023 Category: Cancer & Oncology Authors: Serge Evrard Source Type: research
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023
We report here the summary of the votes, discussions and conclusions of the Saint-Paul-de-Vence 2022-2023 RPCs.PMID:38061827 | DOI:10.1016/S0007-4551(23)00473-3 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 7, 2023 Category: Cancer & Oncology Authors: Joseph Gligorov Marc-Antoine Benderra Xavier Barthere Louise de Forceville Eric Charles Antoine Paul Henri Cottu Suzette Delaloge Jean-Yves Pierga Yazid Belkacemi Gilles Houvenaegel Pascal Pujol Sofia Rivera Marc Spielmann Fr édérique Penault-Llorca Moi Source Type: research
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023
We report here the summary of the votes, discussions and conclusions of the Saint-Paul-de-Vence 2022-2023 RPCs.PMID:38061827 | DOI:10.1016/S0007-4551(23)00473-3 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - December 7, 2023 Category: Cancer & Oncology Authors: Joseph Gligorov Marc-Antoine Benderra Xavier Barthere Louise de Forceville Eric Charles Antoine Paul Henri Cottu Suzette Delaloge Jean-Yves Pierga Yazid Belkacemi Gilles Houvenaegel Pascal Pujol Sofia Rivera Marc Spielmann Fr édérique Penault-Llorca Moi Source Type: research
